New cancer therapy from Yibin Kang's lab holds potential to switch off major cancer types without side effects

Imagine you could cure cancer by targeting one tiny gene. Imagine that same gene occurred in every major cancer, including breast, prostate, lung

Related Keywords

China ,Jersey ,Yong Wei ,Guangdong ,Yong Tang ,Hainan ,United States ,Liling ,Jiangxi ,American ,Yi Zhou Jiang ,Susang Komen ,Hahn Kim ,Nicole Wang ,Xin Lu ,Chi Van Dang ,Heath Smith ,Cheng Guo Wu ,Stacy Remiszewski ,Zhi Ming Shao ,Flynn Larsen ,Michael Raba ,Michelle Rowicki ,Joseph Bertino ,Songyang Wu ,Minhong Shen ,Yibin Kang ,Yongna Xing ,Aiping Zheng ,Heatha Smith ,Sheng Zhao ,Johnf Jin ,Lanjing Zhang ,Breast Cancer Research Foundation ,National Cancer Institute ,Department Of Defense Breast Cancer Research Program ,Brewster Foundation ,Jersey Commission On Cancer Research ,Novartis ,University Of Notre Dame ,Dana Farber Cancer Institute ,Baylor College Of Medicine ,American Cancer Society ,National Institutes Of Health ,Ludwig Cancer Research ,Small Molecule Screening Center ,Princeton Department Of Chemistry ,University Of Pennsylvania ,Ludwig Institute For Cancer Research ,Karmanos Cancer Institute In Detroit ,Parke Davis Professor ,Molecular Biology ,Princeton Branch ,Ludwig Institute ,National Cancer ,Ludwig Cancer ,Ironman Arizona ,Karmanos Cancer Institute ,Notre Dame ,Liling Wan ,Baylor College ,Xiang Hang ,Wayne State ,Min Yuan ,National Institutes ,Defense Breast Cancer Research Program ,New Jersey Commission ,Cancer Research ,Preclinical Imaging ,Flow Cytometry Shared Resources ,Rutgers Cancer Institute ,New Jersey ,